Optimisation of Care in Vulnerable HIV Infected Individuals

  • End date
    Dec 15, 2023
  • participants needed
  • sponsor
    Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Updated on 15 February 2021


Antiretroviral therapy is currently the only way to control HIV disease progression in HIV infected subjects and to prevent transmission. However a sustained virological control through antiretroviral therapy is requested for these objectives. There is currently 8-10% of patients who failed therapy for many reasons other than virological resistance including social unstability, psychiatric disorders, migrant status, drug or alcohol addictions. Because many of these vulnerabilities can be managed and patients helped for following adequately cares and treatments, study team designed the OPTICARE Program to help reduce impact of the patients' vulnerabilities.

The OPTICARE study is designed as a prospective implementation interventional study which aims to improve retention in care among vulnerable HIV infected patients over 48 weeks.

The OPTICARE program is a support program dedicated to patients either lost to follow up or in highly fraility situation that will offer an individualized care management to fill their gaps towards optimized care and control of viral replication. Our aim is, in patients virally failing in relation with poor adherence to care and treatment to test first part whether tracking proactively lost to follow up patients or detecting frail individuals at risk of lost to care is effective and secondly to evaluate the efficacy, the feasibility and the acceptability of an intervention tailored to each individual to get them to treatment success with viral suppression. In our context, a randomized approach would not be seen as ethical or possible in an environment where investigators need to evaluate such intervention as a pilot approach. Investigators therefore enrolled patients in a cohort population study OPTICARE program aim to actively identify vulnerable HIV+ population and promote optimal access to health care to this population using retention in care program in order to enable long term HIV infection control.

The primary objective is to assess the feasability and the effectiveness of the OPTICARE program. The OPTICARE program aims to propose an individualized care to vulnerable HIV infected patients (UNAIDS/Second 90% goal) and to drive them to treatment success (UNAIDS/Third 90% goal) within a one-year period.


The OPTICARE program is an individualized program proposed to vulnerable HIV infected patients according to a baseline evaluation of the clinical, social, psychological and cultural aspects.

Once enrolled in the OPTICARE program, each patient will benefit of:

  • A comprehensive and complete check up personal interview, through a daily visit, with a physician, an educational nurse, a social worker and a cultural mediator (if needed), in order to identify mains issues
  • A specific follow up will be set up with obligatory visits at week 4, week 12, week 24, week 36 and week 48 to assess the evolution of the previously identified issues. If needed, additional visits will be set up.
  • Regular (Day 15 and monthly) phone calls will be set up during the first six months of the OPTICARE program.
  • Each patient will be accompanied by a tutoring nurse who will be in direct contact with the patient.

Regarding the specific needs, each patient may benefit of:

  • a personal assistance to complete administrative procedures (update health insurance, assistance to fill administrative papers, provide a budget for photo ID, transport tickets)
  • a personalized medical follow up with regular phone calls, home visits (if the patient agrees), assistance in taking HIV medication (set up pillbox, therapeutic education)
  • a close psychological and social support (connection with HIV organizations, participation to monthly support group)
  • a specific assistance related to dependence issues (connection with addiction organization, sex therapist consultation)

A multidisciplinary team (physician, educational nurse, psychotherapist, social worker and cultural mediator) will proactively assist the patient (home visits, recall) during a one year follow up.

The program is initially proposed to the patient. In case of non-acceptance, the patient can further join the program after 3 months.

Patients who do not accept the OPTICARE program will be followed up in standard of care according to French HIV management guidelines. (https://cns.sante.fr/actualites/prise-en-charge-du-vih-recommandations-du-groupe-dexperts/). All administratives and social procedures will be given to the social district.

Condition HIV infection, HIV Infections, Immunodeficiency, Primary Immunodeficiency Disorders, Primary Immunodeficiency Disorders, HIV Infections, human immunodeficiency virus, hiv disease
Treatment Opticare study
Clinical Study IdentifierNCT03799276
SponsorCentre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Last Modified on15 February 2021


Yes No Not Sure

Inclusion Criteria

Patients Lost to follow-up defined as a patient with no clinical visit
In the 12 months period for patients > 250/mm3 CD4 cells or
In the 6 months period for patients < 250/mm3 CD4 cells or
In the 3 months period following a new HIV + diagnosis or an AIDS defining illnesses
AND with HIV plasma viral load > 400 cp/ml (following French HIV guidelines)
\. HIV+ patients with virological failure defined as HIV plasma viral load
(pVL) > 400 cp/ml (2 determinations with at least two weeks apart)
\. HIV+ patients presenting with an AIDS defining (<3 months) event in a
context of lost to care prior to the event
\. HIV+ patients newly diagnosed with virological failure 6 months after ART
initiation (virological failure defined by two HIV plasma viral load > 50cp/ml
following French HIV guidelines ) and with one of the following vulnerable
risk factors
Social frailty (lack of health insurance, homeless, accommodation by family/friends, post incarceration)
Migrants with a first arrival in France in the last 6 months
Women in postpartum period (3 months after delivery)
Psychiatric disease
Intravenous drug users, alcohol consumers (women > 40g/day or > 2 standard drinks /day; men > 60g/day ou > 3 standard drinks/day)
A standard glass is defined by a quantity of pure alcohol of 10 grams
corresponding to approximately 10 cl of wine, 25 cl of beer at 5% vol, or 3 cl
of alcohol at 40% vol

Exclusion Criteria

Patients unwilling to participate
Patients with HIV plasma viral load < 50 cp/ml
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note